Application no. and date | 12745883.4 (espacenet) (Federated) (European Patent Register), 20120814 | Patent/reg. no. and date | DK/EP 2744826, 20220209 | Publication date | 20140625 | Priority no. and date | US 201161523862 P, 20110816, EP 11177660, 20110816 | EP pub. no. and date |
EP 2744826 20140625 | Effective date | | Applicant/owner | Incyte Corporation, 1801 Augustine Cut-Off
Wilmington
Delaware 19803
, US | Applicant ref. no. | P79011DK01 | Inventor | WINDERLICH, Mark, Implerstr. 52
81371 München, DE, STEIDL, Stefan, Ebenböckstr. 25
81241 München, DE, KROHN, Susanne, Haidelweg 22a
81241 München, DE, ROJKJAER, Lisa, Frohmoosstrasse 38h
CH-8908 Hedingen, CH, AMERSDORFFER, Jutta, Georg-Lang-Strase
85421 Hebertshausen, DE | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | A61K 39/395 (2006.01) , C07K 16/28 (2006.01) | Title | KOMBINATIONSTERAPI MED ET ANTI-CD19-ANTISTOF OG EN PURIN-ANALOG | Int. application no. | EP2012065904 | Int. publication no. | WO2013024095 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|